Tirzepatide*
CAS
2023788-19-2
MF
C225H348N48O68
MW
4813.527
Purity
98%
Solubility
DMSO
Appearance
White powder
Storage Temp
-20℃ ± 5℃
Indication
Type II diabetes
Description

Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

Documents

DMF + FDA EIR